Karolina Rittner, et al. AACR 2018, April 2018 – Abstract available on the AACR 2018 website Download the poster here Poster Presentation
Year: 2018
Transgene Presents Data on a Novel Viral Vector with Remarkable Anticancer Activity at AACR 2018
20180418 AACR 2018 poster PCPV – EN
TG6002: a novel oncolytic and vectorized gene-prodrug therapy approach to treat glioblastoma
Johann Foloppe, et al. International Oncolytic Virus Conference, April 2018 Download the poster here Poster Presentation
H. C. Wainwright Global Life Sciences Conference: April 9, 2018 – Monte Carlo, Monaco
Transgene to announce major clinical results in 2018 and achieve promising progress on its new oncolytic viruses
20180321-Resultats-2017-EN
Corporate presentation
Corporate Presentation Download (PDF)
Transgene to Present Data on a Novel Viral Vector with Superior Anti-Cancer Immunotherapeutic Activity at AACR 2018
20180315 PR AACR LB poster accepted
First Chronic Hepatitis B Patient Dosed in China in a Phase 1 Trial of T101 (Transgene’s TG1050 Technology)
20180117 PR FPI T101
First Patient Dosed in a Phase 2 Trial with Transgene’s TG4010 + Nivolumab + Chemotherapy for the First-Line Treatment of Lung Cancer (NSCLC)
20180116 PR FPI TG4010 1L EN